Regeneron Sets Out Timing Expectations For Dupixent Biosimilars

Originator Indicates Expected Market Formation Dates For Dupilumab Rivals To $12bn Brand

 
• By Dave Wallace
  
Dupixent syringe
Dupixent will face biosimilar competition – but when? • Source: Shutterstock

More from Biosimilars

More from Products